Da hipertensão à insuficiência cardíaca /

Por Cleland, J. G. F., McMurray, J.
Publicado em 1997

Is aspirin safe in heart failure? More data

Por Cleland, J G F, Poole-Wilson, P
Publicado em 1996

Multidisciplinary interventions in heart failure

Por Clark, A L, Cleland, J G F
Publicado em 2005

Angiotensin converting enzyme inhibition in heart failure

Por Cleland, J. G. F., Dargie, H. J., Robertson, J. I. S.
Publicado em 1984

The utility of a comprehensive cardiac magnetic resonance examination for the evaluation of patients with heart failure

Por Nikitin, N P, de Silva, R, Cleland, J G F
Publicado em 2004

Chronic heart failure, chronotropic incompetence, and the effects of β blockade

Por Witte, K K A, Cleland, J G F, Clark, A L
Publicado em 2006

Effect of a community heart failure clinic on uptake of β blockers by patients with obstructive airways disease and heart failure

Por Shelton, R J, Rigby, A S, Cleland, J G F, Clark, A L
Publicado em 2006

Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study

Por Shah, D, Azhar, M, Oakley, C M, Cleland, J G F, Nihoyannopoulos, P
Publicado em 1994

Excessive breathlessness in patients with diastolic heart failure

Por Witte, K K A, Nikitin, N P, Cleland, J G F, Clark, A L
Publicado em 2006

Unmasking the truth

Por Cullington, D, Esmail, S, Hurren, S, Cleland, J G F, Clark, A L, Alamgir, M F
Publicado em 2011

Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity

Por Morant, S V, McMahon, A D, Cleland, J G F, Davey, P G, MacDonald, T M
Publicado em 2004

Pattern of ventilation during exercise in chronic heart failure

Por Witte, K K A, Thackray, S D R, Nikitin, N P, Cleland, J G F, Clark, A L
Publicado em 2003

The effects of α and β blockade on ventilatory responses to exercise in chronic heart failure

Por Witte, K K A, Thackray, S D R, Nikitin, N P, Cleland, J G F, Clark, A L
Publicado em 2003

Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure

Por Witte, K K A, Nikitin, N P, De Silva, R, Cleland, J G F, Clark, A L
Publicado em 2004

Mode of death in heart failure: findings from the ATLAS trial

Por Poole-Wilson, P A, Uretsky, B F, Thygesen, K, Cleland, J G F, Massie, B M, Rydén, L
Publicado em 2003

Renal artery stenosis: Authors' reply

Por Choudhri, A H, Cleland, J G F, Rowlands, P C, Tran, T L, McCarty, M, Al-Kutoubi, M A O
Publicado em 1991

Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study

Por Prasad, S K, Dargie, H J, Smith, G C, Barlow, M M, Grothues, F, Groenning, B A, Cleland, J G F, Pennell, D J
Publicado em 2006

Relation between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface ECG: a report from the Euro heart failure survey

Por Velavan, P, Khan, NK, Rigby, A S, Goode, K, Komajda, M, Follath, F, Swedberg, K, Madeira, H, Clark, A L, Cleland, J G F
Publicado em 2006

Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study

Por Bellenger, N G, Rajappan, K, Rahman, S L, Lahiri, A, Raval, U, Webster, J, Murray, G D, Coats, A J S, Cleland, J G F, Pennell, D J
Publicado em 2004

Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction

Por Nikitin, N P, Loh, P H, de Silva, R, Ghosh, J, Khaleva, O Y, Goode, K, Rigby, A S, Alamgir, F, Clark, A L, Cleland, J G F
Publicado em 2006